{"id":"https://openalex.org/W194597349","doi":"https://doi.org/10.1096/fasebj.22.2_supplement.474","title":"Antigen presentation by lymph node stroma: Potential for tolerogenic immunotherapy","display_name":"Antigen presentation by lymph node stroma: Potential for tolerogenic immunotherapy","publication_year":2008,"publication_date":"2008-04-01","ids":{"openalex":"https://openalex.org/W194597349","doi":"https://doi.org/10.1096/fasebj.22.2_supplement.474","mag":"194597349"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.22.2_supplement.474","doi":"https://doi.org/10.1096/fasebj.22.2_supplement.474","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.2_supplement.474","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007604692","display_name":"Ai-ris Yonekura Collier","orcid":"https://orcid.org/0000-0002-8539-3960","observed_orcids":["https://orcid.org/0000-0002-8539-3960"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210092658","display_name":"Harvard\u2013MIT Division of Health Sciences and Technology","ror":"https://ror.org/00jjeh629","country_code":"US","type":"education","lineage":["https://openalex.org/I4210092658"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ai\u2010ris Yonekura Collier","raw_affiliation_strings":["Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","Harvard\u2010MIT Division of Health Sciences &Technology Harvard Medical School Boston MA","Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA","Harvard-MIT Division of Health Sciences &Technology, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard\u2010MIT Division of Health Sciences &Technology Harvard Medical School Boston MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210092658","https://openalex.org/I63966007"]},{"raw_affiliation_string":"Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard-MIT Division of Health Sciences &Technology, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210092658","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001849997","display_name":"Erika D. Reynoso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Reynoso","raw_affiliation_strings":["Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069841345","display_name":"Melissa Yuwono Tjota","orcid":"https://orcid.org/0000-0002-5869-3175","observed_orcids":["https://orcid.org/0000-0002-5869-3175"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Tjota","raw_affiliation_strings":["Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011465411","display_name":"Shannon J. Turley","orcid":"https://orcid.org/0000-0002-0444-3031","observed_orcids":["https://orcid.org/0000-0002-0444-3031","https://orcid.org/0000-0002-0307-908X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon J Turley","raw_affiliation_strings":["Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology & AIDS Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"S2","first_page":"474","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.36500000953674316,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/t-cell-tolerance","display_name":"T cell tolerance","score":0.6460000276565552},{"id":"https://openalex.org/keywords/negative-selection","display_name":"negative selection","score":0.6570000052452087},{"id":"https://openalex.org/keywords/medullary-thymic-epithelial-cells","display_name":"medullary thymic epithelial cells","score":0.9570000171661377},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.9760000109672546},{"id":"https://openalex.org/keywords/treg-differentiation","display_name":"Treg differentiation","score":0.5550000071525574},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mhc-class-i-and-ii","display_name":"MHC class I and II","score":0.7620000243186951},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.9169999957084656},{"id":"https://openalex.org/keywords/tolerogenic-vaccines","display_name":"tolerogenic vaccines","score":0.8180000185966492},{"id":"https://openalex.org/keywords/graft-rejection","display_name":"graft rejection","score":0.9179999828338623},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8619999885559082},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.9509999752044678}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5934562683105469},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.587929904460907},{"id":"https://openalex.org/C2778297628","wikidata":"https://www.wikidata.org/wiki/Q5009843","display_name":"CD80","level":5,"score":0.5828055143356323},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.56074059009552},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5312114953994751},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5249716639518738},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5057063102722168},{"id":"https://openalex.org/C2778830056","wikidata":"https://www.wikidata.org/wiki/Q606766","display_name":"Central tolerance","level":4,"score":0.5043407678604126},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.49976491928100586},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.47029873728752136},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.4554649293422699},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.45050883293151855},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4263029396533966},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4051768183708191},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3272516131401062},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.2598157525062561},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16813859343528748},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04810050129890442}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.22.2_supplement.474","doi":"https://doi.org/10.1096/fasebj.22.2_supplement.474","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.2_supplement.474","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5899999737739563,"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W117575471","https://openalex.org/W2109445521","https://openalex.org/W7002128469","https://openalex.org/W2103144700","https://openalex.org/W7095353332","https://openalex.org/W2144276100","https://openalex.org/W2112819201","https://openalex.org/W2576305170","https://openalex.org/W2129112743","https://openalex.org/W7097937851"],"abstract_inverted_index":{"Developing":[0],"T":[1,24,53,103,119,139],"cells":[2,14,18,25],"that":[3,126],"recognize":[4],"self\u2010antigen":[5],"undergo":[6,175],"negative":[7],"selection":[8],"mediated":[9],"by":[10,36],"medullary":[11],"thymic":[12],"epithelial":[13],"(mTECs)":[15],"and":[16,88,90,94,101,178],"dendritic":[17],"(DCs)":[19],"in":[20,80,106,135,156,162,191,194,204],"the":[21,187,198],"thymus.":[22],"Self\u2010reactive":[23],"escaping":[26],"central":[27],"tolerance":[28,59,150,193],"were":[29],"thought":[30],"to":[31,67,77,98,116,152,158],"be":[32],"regulated":[33],"peripherally":[34],"only":[35],"DCs.":[37],"Our":[38],"lab":[39],"recently":[40],"described":[41],"a":[42,75],"novel":[43],"lymph":[44],"node":[45],"stroma":[46],"cell":[47,54,104],"(LNSC)":[48],"capable":[49],"of":[50,62,167,189],"inducing":[51,121],"antigen\u2010specific":[52,108],"deletional":[55],"tolerance.":[56],"LNSCs":[57,72,79,172,190,196],"mediate":[58],"through":[60],"expression":[61,134],"peripheral":[63],"tissue":[64],"antigens,":[65],"similarly":[66],"mTECs.":[68],"To":[69],"better":[70],"characterize":[71],"we":[73],"developed":[74],"system":[76],"expand":[78],"vitro":[81],".":[82],"LNSC":[83,97,110,127,142],"express":[84],"MHC":[85],"class":[86],"I":[87],"II,":[89],"costimulatory":[91],"molecules,":[92],"CD80":[93],"PD\u2010L1,":[95],"enabling":[96],"interface":[99],"with":[100,129],"modulate":[102],"responses":[105],"an":[107],"manner.":[109],"take":[111],"up":[112],"antigen":[113],"for":[114,182,200],"cross\u2010presentation":[115],"CD8":[117],"+":[118,138],"cells,":[120,140],"proliferation.":[122],"Preliminary":[123],"data":[124],"show":[125],"pulsed":[128],"MHCII\u2010restricted":[130],"peptide":[131],"induce":[132,143],"FOXP3":[133],"na\u00efve":[136],"CD4":[137],"suggesting":[141],"Treg":[144],"differentiation.":[145],"Because":[146],"DCs":[147],"transition":[148],"from":[149],"inducers":[151],"potent":[153],"immune":[154],"activators":[155],"response":[157],"inflammation,":[159],"their":[160],"use":[161,201],"tolerogenic":[163],"vaccines":[164],"presents":[165],"issues":[166],"clinical":[168],"safety.":[169],"By":[170],"contrast,":[171],"do":[173],"not":[174],"this":[176],"transformation":[177],"may":[179],"prove":[180],"safer":[181],"therapy.":[183],"We":[184],"will":[185],"test":[186],"efficacy":[188],"reinforcing":[192],"vivo.":[195],"have":[197],"potential":[199],"as":[202],"therapy":[203],"graft":[205],"rejection":[206],"or":[207],"autoimmune":[208],"disease":[209],"like":[210],"type":[211],"1":[212],"diabetes.":[213]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}